Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46721 publications
Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome.
Journal: JAAD international
Published: December 16, 2025
Atopic dermatitis beyond the skin: Characterizing skin pain in the "Scars of Life" study.
Journal: JAAD international
Published: December 16, 2025
Associations of Circulating Metabolites with Childhood Allergy and Common Allergic Diseases: A Mendelian Randomization Study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: December 15, 2025
Utilizing Data Mining to Improve Asthma Control in Children: A Study on Influential Factors.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: December 15, 2025
Immunological Differences in Atopic Dermatitis Across Age Groups: Insights from Single-Cell Multi-Omics.
Journal: bioRxiv : the preprint server for biology
Published: December 15, 2025
Cost per responder analysis of lebrikizumab versus tralokinumab in moderate to severe atopic dermatitis.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 15, 2025
Exploring the relationship between serum 25-hydroxyvitamin D levels and allergic rhinitis severity in the pediatric population.
Journal: Postgraduate medicine
Published: December 15, 2025
Head and neck atopic Dermatitis: are janus kinase inhibitors a game changer?
Journal: Expert opinion on pharmacotherapy
Published: December 14, 2025
Adverse Food Reactions in Dogs and Cats.
Journal: The Veterinary clinics of North America. Small animal practice
Published: December 14, 2025
The Dual Role of Staphylococcus epidermidis in Atopic Dermatitis: Pathobiont and Protector.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: December 12, 2025
Deucravacitinib could be an effective and safe choice in patients affected with psoriasis and atopic dermatitis (Psorema)?
Journal: Italian journal of dermatology and venereology
Published: December 11, 2025
Last Updated: 01/07/2026